Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
6Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Bright Minds Biosciences Inc. (DRUG) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
1Distinct source URLs
3High confidence
0.716Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Bright Minds Biosciences Inc. Suppliers
Ticker
Name
Confidence
Evidence
UIC
UIC
92%
Pursuant to the terms and conditions of the Exclusive License Agreement, UIC granted the Company an exclusive license to the Inventions
Reciprocal relationship from AARD graph: Reciprocal relationship from DRUG graph: Reciprocal relationship from AARD graph: Reciprocal relationship from DRUG graph: Reciprocal relationship from AARD g…
Bright Minds Biosciences Inc. Customers
Ticker
Name
Confidence
Evidence
ASTRAZENECA-PHARMACEUTICAL-COMPANY
ASTRAZENECA-PHARMACEUTICAL-COMPANY
62%
September 22, 2022 (Chief Scientific Officer) David Weiner (1)(2)(3)(4) , New York, USA 60 Director February 16, 2023 ___________________________ Notes (1) Member of the Audit Committee. (2) Member o…
Reciprocal relationship from AZN graph: Reciprocal relationship from DRUG graph: Reciprocal relationship from AZN graph: Reciprocal relationship from DRUG graph: September 22, 2022 (Chief Scientific …
B-C-LTD
B-C-LTD
62%
declare dividends, any gain on your investment will need to result from an appreciation in the price of our Common Shares. There will therefore be fewer ways in which you are able to make a gain on y…
DMG-BLOCKCHAIN-SOLUTIONS-INC
DMG-BLOCKCHAIN-SOLUTIONS-INC
62%
September 22, 2022 (Chief Scientific Officer) David Weiner (1)(2)(3)(4) , New York, USA 60 Director February 16, 2023 ___________________________ Notes (1) Member of the Audit Committee. (2) Member o…
PAGE-BRIGHT-MINDS-BIOSCIENCES-INC
PAGE-BRIGHT-MINDS-BIOSCIENCES-INC
62%
lly enforceable right to offset the recognized amounts and intends either to settle on a net basis, or to realize the asset and settle the liability simultaneously. Impairment of financial assets The…
XEMPLAR-ENERGY-CORP
XEMPLAR-ENERGY-CORP
62%
September 22, 2022 (Chief Scientific Officer) David Weiner (1)(2)(3)(4) , New York, USA 60 Director February 16, 2023 ___________________________ Notes (1) Member of the Audit Committee. (2) Member o…
Bright Minds Biosciences Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
DRUG-DEBT
Debt stack $59,536
90%
Market cache reports total debt of $59,536.
Bright Minds Biosciences Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Bright Minds Biosciences Inc..
Bright Minds Biosciences Inc. Ownership
Holder
Name
Confidence
Evidence
DRUG-OWNER-JANUS-HENDERSON-GROUP-PLC
JANUS HENDERSON GROUP PLC
90%
13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 93 tracked holders.
Bright Minds Biosciences Inc. Extended Supply Chain Network
